Zdravi-fit s.r.o.

Research at Zdravi-fit s.r.o. includes studies in bacterial infections focused on preventing serious disease caused by invasive Escherichia coli. The work is centered on evaluating whether a new vaccine approach can help reduce the risk of first infection events in older adults.

• Prevention of invasive E. coli disease in adults at elevated risk
• Testing a vaccine strategy aimed at lowering severe infection events
• Clinical focus on infection prevention in older patients

This area reflects a broader effort to improve protection against serious microbial diseases through preventive research rather than treatment alone.

The site is also studying cardiovascular disease, with attention to medication-related peripheral edema in people using amlodipine. These trials aim to better understand symptom burden and compare ways to measure and manage swelling in the legs.

• Assessment of peripheral edema in patients receiving long-term amlodipine
• Comparing methods for measuring swelling in both legs
• Evaluating patient comfort and tolerability alongside clinical findings

This research supports better everyday management of hypertension-related treatment effects and may help guide more patient-friendly care.

Clinical research in digestive system health at this site examines how antibiotic treatment affects the gut microbiota in patients being treated for erythema migrans, an early form of Lyme borreliosis. The goal is to understand how supportive therapy may help maintain intestinal balance during treatment.

• Studying gut microbiota changes during antibiotic therapy
• Evaluating the effect of Saccharomyces boulardii on intestinal health
• Supporting patients treated for early Lyme borreliosis

This line of research explores whether adding a probiotic approach can help preserve digestive system function while patients receive necessary antibiotics.

At Zdravi-fit s.r.o., viral disease research includes studies in COVID-19 among outpatients who are at higher risk of becoming severely ill. The purpose is to evaluate whether a new treatment can help prevent worsening of the infection and improve outcomes outside the hospital setting.

• Research in COVID-19 for nonhospitalized high-risk participants
• Comparing a potential antiviral treatment with placebo
• Focusing on prevention of progression to severe illness

This work contributes to ongoing efforts in viral infection management by testing therapies designed for earlier intervention.